Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 380 Gastric Bypass in Morbid Obesity Postoperative Changes in Metabolic , Inflammatory and Gut Regulatory Peptides

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The effects of two different hypocaloric diets on glucagon-like peptide 1 in obese adults, relation with insulin response after weight loss.

  2009cited by this paper
• Ghrelin and Obestatin Levels in Severely Obese Women Before and After Weight Loss After Roux-en-Y Gastric Bypass Surgery

  2009cited by this paper
• Serum C-Reactive Protein and White Blood Cell Count in Morbidly Obese Surgical Patients

  2009cited by this paper
• Visceral Adipose Tissue Loss and Insulin Resistance 6 Months after Laparoscopic Gastric Banding Surgery: A Preliminary Study

  2009cited by this paper
• Enterohormonal Changes After Digestive Adaptation: Five-Year Results of a Surgical Proposal to Treat Obesity and Associated Diseases

  2008cited by this paper
• Is a Pouch Compulsory in Roux-en-Y Gastric Bypass After Failed Adjustable Gastric Banding?

  2008cited by this paper
• Effect of 6‐Month Calorie Restriction and Exercise on Serum and Liver Lipids and Markers of Liver Function

  2008cited by this paper
• Feeding Behavior in Rats Subjected to Gastrectomy or Gastric Bypass Surgery

  2008cited by this paper
• GLP‐1 and Appetite Responses to a Meal in Lean and Overweight Adolescents Following Exercise

  2008cited by this paper
• Effects of Gastric Bypass and Gastric Banding on Glucose Kinetics and Gut Hormone Release

  2008cited by this paper
• Peptide YY levels are associated with appetite suppression in response to long-chain fatty acids.

  2008cited by this paper
• Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery

  2008influential reference
• Weight Loss, Appetite Suppression, and Changes in Fasting and Postprandial Ghrelin and Peptide-YY Levels After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: A Prospective, Double Blind Study

  2008cited by this paper
• Quality of Life After Bariatric Surgery—A Comparative Study of Laparoscopic Banding vs. Bypass

  2008cited by this paper
• Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin.

  2008cited by this paper
• Different Effect of Laparoscopic Roux-en-Y Gastric Bypass and Open Biliopancreatic Diversion of Scopinaro on Serum PYY and Ghrelin Levels

  2008cited by this paper
• The Effect of Laparoscopic Gastric Banding Surgery on Plasma Levels of Appetite-Control, Insulinotropic, and Digestive Hormones

  2008cited by this paper
• The effect of feeding frequency on insulin and ghrelin responses in human subjects

  2008cited by this paper
• Control of gastric acid secretion in health and disease.

  2008cited by this paper
• Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

  2008cited by this paper
• Gene expression profiling of human skeletal muscle in response to stabilized weight loss.

  2008cited by this paper
• Epidemiology of cytokines: the Women On the Move through Activity and Nutrition (WOMAN) Study.

  2008cited by this paper
• High adiponectin concentrations are associated with the metabolically healthy obese phenotype.

  2008cited by this paper
• Health-related Quality of Life in Adult Patients with Morbid Obesity Coming for Bariatric Surgery

  2008cited by this paper
• Selective Downregulation of the High–Molecular Weight Form of Adiponectin in Hyperinsulinemia and in Type 2 Diabetes

  2007cited by this paper
• Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study

  2007cited by this paper
• Decreased Basal Levels of Glucagon-Like Peptide-1 after Weight Loss in Obese Subjects

  2007cited by this paper
• Peptide YY release in anorectic patients after liquid meal.

  2007cited by this paper
• Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.

  2007cited by this paper
• Gastric Bypass Surgery is Associated with Reduced Inflammation and Less Depression: a Preliminary Investigation

  2007cited by this paper
• Long-term mortality after gastric bypass surgery.

  2007cited by this paper
• Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients.

  2007cited by this paper
• Prevalent esophageal body motility disorders underlie aggravation of GERD symptoms in morbidly obese patients following adjustable gastric banding.

  2006cited by this paper
• Acute-Phase Serum Amyloid A: An Inflammatory Adipokine and Potential Link between Obesity and Its Metabolic Complications

  2006cited by this paper
• Pancreatic polypeptide in obese children before and after weight loss

  2006cited by this paper
• Ghrelin and Peptide YY Levels after a Variant of Biliopancreatic Diversion with Roux-en-Y Gastric Bypass versus after Colectomy: A Prospective Comparative Study

  2006cited by this paper
• Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.

  2006cited by this paper
• Variations in Postprandial Ghrelin Status following Ingestion of High-Carbohydrate, High-Fat, and High-Protein Meals in Males

  2006cited by this paper
• Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people.

  2006cited by this paper
• Progressive rise in gut hormone levels after Roux‐en‐Y gastric bypass suggests gut adaptation and explains altered satiety

  2006cited by this paper
• Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters

  2006cited by this paper
• Lower mean weight after 14 days intravenous administration peptide YY3–36 (PYY3–36) in rabbits

  2006cited by this paper
• Prohormone convertases differentially process pro-neurotensin/neuromedin N in tissues and cell lines

  2006cited by this paper
• Is Gastrin Partially Responsible for Body Weight Reduction after Gastric Bypass?

  2006cited by this paper
• Critical role for peptide YY in protein-mediated satiation and body-weight regulation.

  2006influential reference
• Increased Serum Amyloid A Concentrations in Morbid Obesity Decrease after Gastric Bypass

  2006cited by this paper
• Serum Amyloid A: A Marker of Adiposity‐induced Low‐grade Inflammation but Not of Metabolic Status

  2006cited by this paper
• Serum Ghrelin, Leptin and Adiponectin Levels before and after Weight Loss: Comparison of Three Methods of Treatment – A Prospective Study

  2006cited by this paper
• Wheat-fibre-induced changes of postprandial peptide YY and ghrelin responses are not associated with acute alterations of satiety

  2006cited by this paper
• Peptide YY Levels Are Elevated After Gastric Bypass Surgery

  2006cited by this paper
• Subcutaneous adipose tissue cytokine production is not responsible for the restoration of systemic inflammation markers during weight loss

  2006cited by this paper
• Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes.

  2005cited by this paper
• The satiating effect of dietary protein is unrelated to postprandial ghrelin secretion.

  2005cited by this paper
• Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents.

  2005cited by this paper
• Decreased glucagon-like peptide 1 release after weight loss in overweight/obese subjects.

  2005cited by this paper
• Peptide YY(3-36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques.

  2005cited by this paper
• Transcriptomics applied to obesity and caloric restriction.

  2005cited by this paper
• The effect of weight loss after gastric bypass on C-reactive protein levels.

  2005cited by this paper
• A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations.

  2005cited by this paper
• Peptide YY is a regulator of energy homeostasis in obese children before and after weight loss.

  2005cited by this paper
• Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients.

  2005cited by this paper
• Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy.

  2005cited by this paper
• Orlistat for obesity: benefits beyond weight loss.

  2005cited by this paper
• The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats.

  2005cited by this paper
• Diet-induced weight loss is associated with decreases in plasma serum amyloid a and C-reactive protein independent of dietary macronutrient composition in obese subjects.

  2005cited by this paper
• Stimulation of neurogenesis in rat nucleus of the solitary tract by ghrelin.

  2005cited by this paper
• Changes in Glucagon-like Peptide-1 (GLP-1) Secretion after Biliopancreatic Diversion or Vertical Banded Gastroplasty in Obese Subjects

  2005cited by this paper
• Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin.

  2005cited by this paper
• Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study.

  2005cited by this paper
• Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery.

  2005cited by this paper
• Long-term effects of a high-protein, low-carbohydrate diet on weight control and cardiovascular risk markers in obese hyperinsulinemic subjects

  2004cited by this paper
• Intravenous administration of ghrelin stimulates growth hormone secretion in vagotomized patients as well as normal subjects.

  2004cited by this paper
• Parasympathetic blockade attenuates augmented pancreatic polypeptide but not insulin secretion in Pima Indians.

  2004cited by this paper
• Serum adiponectin and leptin levels in patients with lipodystrophies.

  2004cited by this paper
• Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies.

  2004cited by this paper
• Ghrelin stimulates neurogenesis in the dorsal motor nucleus of the vagus

  2004cited by this paper
• Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial.

  2004cited by this paper
• Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism.

  2004cited by this paper
• Effect of weight loss on cardiac synchronization and proinflammatory cytokines in premenopausal obese women.

  2004cited by this paper
• Brain-gut axis and its role in the control of food intake.

  2004cited by this paper
• Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction.

  2004cited by this paper
• Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.

  2004cited by this paper
• Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines.

  2004cited by this paper
• Fasting Plasma Ghrelin Concentrations 6 Months after Gastric Bypass are not Determined by Weight Loss or Changes in Insulinemia

  2004cited by this paper
• Reduction in C-reactive protein through cardiac rehabilitation and exercise training.

  2004cited by this paper
• Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers

  2004cited by this paper
• The effects of gastric surgery on systemic ghrelin levels in the morbidly obese.

  2004cited by this paper
• Inflamed about obesity

  2004cited by this paper
• Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition.

  2004cited by this paper
• Alteration of the counterregulatory responses to insulin-induced hypoglycemia and of cognitive function after massive weight reduction in severely obese subjects.

  2003cited by this paper
• Abnormal ghrelin secretion in new onset childhood Type 1 diabetes

  2003cited by this paper
• Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects.

  2003cited by this paper
• Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse.

  2003cited by this paper
• Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials

  2003cited by this paper
• Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.

  2003cited by this paper
• Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.

  2003cited by this paper
• Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans.

  2003cited by this paper
• Meal-related ghrelin suppression requires postgastric feedback.

  2003cited by this paper
• The influence of insulin on circulating ghrelin.

  2003cited by this paper
• Insulin is required for prandial ghrelin suppression in humans.

  2003cited by this paper

• No citing papers are available for this paper.